What will stop the biggest inversion deals cold is a regulation steering Medicare and Medicaid’s purchases of drugs and medical devices elsewhere. If you want to sell to government plans, your tax residence has to match where the operating headquarters is, among other tests.
So, Medicare and Medicaid should simply drop all drugs and medical devices from tax-inverted companies? That’s a good way to make patients pay the price for the US’s disjointed corporate-tax code.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”